Evidence map›Paper›PMID 33252167›Full record

ArticleHuman mutation2021

Detection and validation of novel mutations in MERTK in a simplex case of retinal degeneration using WGS and hiPSC-RPEs model.

Pooja Biswas, Shyamanga Borooah, Hiroko Matsui, Marina Voronchikhina, Jason Zhou, Qais Zawaydeh, Pongali B Raghavendra, Henry Ferreyra, S Amer Riazuddin, Karl Wahlin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Pooja BiswasShiley Eye Institute, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-8545-9296
Shyamanga BorooahShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
Hiroko MatsuiInstitute for Genomic Medicine, University of California, San Diego, La Jolla, California, USA.
Marina VoronchikhinaShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
Jason ZhouShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
Qais ZawaydehShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
Pongali B RaghavendraREVA University, Bengaluru, Karnataka, India.
Henry FerreyraShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
S Amer RiazuddinWilmer Eye Institute, Johns Hopkins Univesity School of Medicine, Baltimore, Maryland, USA.
Karl WahlinShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
Kelly A FrazerInstitute for Genomic Medicine, University of California, San Diego, La Jolla, California, USA.
Radha AyyagariShiley Eye Institute, University of California San Diego, La Jolla, California, USA.
University of California San Diego · USJohns Hopkins University · USManipal Academy of Higher Education · IN

Funding

Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LINDA M ZANGWILL · 2012 to 2026
$10.3M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Molecular Basis of Hereditary Retinal DegenerationsR01EY021237 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA · 2011 to 2020
$5.6M
Molecular mechanism underlying late-onset retinal/macular degenerationR01EY030591 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA · 2020 to 2023
$1.9M
Translational Vision Research Training at UCSDT32EY026590 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2016 to 2025
$854k
Modeling Photoreceptor Development and Disease Using Human Pluripotent Stem CellsR00EY024648 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAHLIN, KARL J · 2016 to 2018
$778k
NCI NIH HHS T32 CA067754NEI NIH HHS P30 EY022589NEI NIH HHS R00 EY024648NEI NIH HHS R01 EY021237NEI NIH HHS R01 EY030591NEI NIH HHS T32 EY026590
6 · The paper itself

Abstract

Inherited retinal degenerations (IRDs) are a group of genetically heterogeneous conditions with a broad phenotypic heterogeneity. Here, we report detection and validation of the underlying cause of progressive retinal degeneration in a nuclear family of European descent with a single affected individual. Whole genome sequencing of the proband and her unaffected sibling identified a novel intron 8 donor splice site variant (c.1296 + 1G>A) and a novel 731 base pair deletion encompassing exon 9 (Chr2:g.112751488_112752218 del) resulting in c.1297_1451del; p.K433_G484fsTer3 in the Mer tyrosine kinase protooncogene (MERTK), which is highly expressed in the retinal pigment epithelium (RPE). The proband carried both variants in the heterozygous state, which segregated with disease in the pedigree. These MERTK variants are predicted to result in the defective splicing of exon 8 and loss of exon 9 respectively. To evaluate the impact of these novel variants, peripheral blood mononuclear cells of the proband and her parents were reprogrammed to humaninduced pluripotent stem cell (hiPSC) lines, which were subsequently differentiated to hiPSC-RPE. Analysis of the proband's hiPSC-RPE revealed the absence of both MERTK transcript and its respective protein as well as abnormal phagocytosis when compared with the parental hiPSC-RPE. In summary, whole genome sequencing identified novel compound heterozygous variants in MERTK as the underlying cause of progressive retinal degeneration in a simplex case. Further, analysis using an hiPSC-RPE model established the functional impact of novel MERTK mutations and revealed the potential mechanism underlying pathology in the proband.

Indexed as

Induced Pluripotent Stem CellsRetinal Degenerationc-Mer Tyrosine KinaseFemaleHumansLeukocytes, MononuclearMutationPhagocytosisRetinal Pigment EpitheliumWhole Genome Sequencingc-Mer Tyrosine KinaseMERTK protein, humandisease modellinghuman iPSC-RPEinherited retinal degenerations (IRDs)RPE phagocytosiswhole genome sequencing

Identifiers

PMID33252167
PMCPMC7878419
OpenAlexW3107222078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.